Literature DB >> 15522267

Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT.

Marcello Ceci1, John Ross, Gianluigi Condorelli.   

Abstract

Cardiomyocytes (CMCs) adapt to physiological or pathological stimuli by undergoing molecular changes which differentiate according to the specificity of the stimulus and eventually generate a phenotype with peculiar molecular characteristics. Here, we review the literature on the molecular mechanisms activated in the CMC during physiologic adaptation to stress, as opposed to maladaptation. The critical role of the IGF-1 receptor/PI3K/Akt signaling pathway during this process is described, including effector targets regulating inotropism and cell size.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522267     DOI: 10.1016/j.yjmcc.2004.06.020

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  14 in total

1.  AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.

Authors:  Guillaume Canaud; Frank Bienaimé; Amandine Viau; Caroline Treins; William Baron; Clément Nguyen; Martine Burtin; Sophie Berissi; Konstantinos Giannakakis; Andrea Onetti Muda; Stefan Zschiedrich; Tobias B Huber; Gérard Friedlander; Christophe Legendre; Marco Pontoglio; Mario Pende; Fabiola Terzi
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

2.  microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.

Authors:  R Kannan Mutharasan; Varun Nagpal; Yoshihiko Ichikawa; Hossein Ardehali
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-12       Impact factor: 4.733

Review 3.  Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.

Authors:  Naveen Sharma; Isidore C Okere; Monika K Duda; David J Chess; Karen M O'Shea; William C Stanley
Journal:  Cardiovasc Res       Date:  2006-11-11       Impact factor: 10.787

4.  Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17.

Authors:  Daniele Catalucci; Michael V G Latronico; Marcello Ceci; Francesca Rusconi; Howard S Young; Paolo Gallo; Marco Santonastasi; Alfonso Bellacosa; Joan Heller Brown; Gianluigi Condorelli
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

Review 5.  Adaptive homeostasis.

Authors:  Kelvin J A Davies
Journal:  Mol Aspects Med       Date:  2016-04-22

6.  Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart.

Authors:  Giannoula L Klement; David Goukassian; Lynn Hlatky; Joseph Carrozza; James P Morgan; Xinhua Yan
Journal:  Front Pharmacol       Date:  2012-06-27       Impact factor: 5.810

7.  The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism.

Authors:  Eleftheria Galatou; Tara Kelly; Antigone Lazou
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.842

8.  Sex-Specific Muscular Maturation Responses Following Prenatal Exposure to Methylation-Related Micronutrients in Pigs.

Authors:  Michael Oster; Nares Trakooljul; Henry Reyer; Annette Zeyner; Eduard Muráni; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Nutrients       Date:  2017-01-18       Impact factor: 5.717

9.  Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.

Authors:  Daniele Catalucci; Deng-Hong Zhang; Jaime DeSantiago; Franck Aimond; Guillaume Barbara; Jean Chemin; Désiré Bonci; Eckard Picht; Francesca Rusconi; Nancy D Dalton; Kirk L Peterson; Sylvain Richard; Donald M Bers; Joan Heller Brown; Gianluigi Condorelli
Journal:  J Cell Biol       Date:  2009-03-23       Impact factor: 10.539

10.  Mechanosensing and Regulation of Cardiac Function.

Authors:  David E Dostal; Hao Feng; Damir Nizamutdinov; Honey B Golden; Syeda H Afroze; Joseph D Dostal; John C Jacob; Donald M Foster; Carl Tong; Shannon Glaser; Fnu Gerilechaogetu
Journal:  J Clin Exp Cardiolog       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.